Tag: Alnylam Pharmaceuticals
Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial
Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their Phase 2 study KARDIA-1. The investigational RNAi ... Read More
Alnylam, Dicerna form RNAi collaboration for alpha-1 liver disease
Alnylam Pharmaceuticals and Dicerna Pharmaceuticals are joining forces to develop and commercialize ribonucleicacid interference therapies (RNAi therapeutics) for the treatment of alpha-1 antitrypsin deficiency-associated liver ... Read More
Alnylam all set for givosiran phase 3 acute hepatic porphyrias trial
Clinical trial news : Alnylam Pharmaceuticals said that it has wrapped up enrollment of patients for a phase 3 trial called ENVISION for evaluating givosiran ... Read More